Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-04-15

AUTHORS

Shinya Furukawa, Teruki Miyake, Hiroaki Miyaoka, Bunzo Matsuura, Yoichi Hiasa

ABSTRACT

IntroductionLuseogliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Unhealthy eating behavior is associated with diabetes, hypertension, and obesity. However, evidence regarding the effect of medications, including SGLT2 inhibitors, on unhealthy eating behavior is limited. This study investigated the association between unhealthy eating behavior and the laboratory and physical findings of Japanese patients with type 2 diabetes given luseogliflozin once daily for 24 weeks.MethodsTwenty-nine patients with type 2 diabetes mellitus were enrolled in a 24-week prospective, open-label, single-arm pilot study. The information regarding unhealthy eating behaviors (eating fast, late dinner, nighttime snack, skipping breakfast, and eating until full) was obtained using self-reported questionnaires.ResultsThe baseline rate of eating fast, late dinner, nighttime snack, skipping breakfast, and eating until full was 51.7%, 24.1%, 24.1%, 10.3% and 55.2%, respectively. After administration of luseogliflozin, fasting plasma glucose, HbA1c, aspartate aminotransferase (ALT), weight, body mass index, and waist measurement all decreased significantly. High-density lipoprotein cholesterol and hematocrit increased significantly. In the healthy eating behavior group, the improvements of fasting plasma glucose and ALT, but not other variables, were attenuated. HbA1c level was significantly improved in patients with eating fast, while other unhealthy eating behaviors attenuated the effect of luseogliflozin for HbA1c. The effect of leseogliflozin on the relationship between eating behavior and weight reduction was inconsistent after administration luseogliflozin.ConclusionLuseogliflozin might be more effective for controlling plasma glucose in patients with type 2 diabetes who have a tendency to eat fast, but it might have less effect on those with other unhealthy eating habits. More... »

PAGES

1073-1082

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-022-01261-9

DOI

http://dx.doi.org/10.1007/s13300-022-01261-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1147145793

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35426601


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Health Services Center, Ehime University, Bunkyo, 790-8577, Matsuyama, Ehime, Japan", 
          "id": "http://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Health Services Center, Ehime University, Bunkyo, 790-8577, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furukawa", 
        "givenName": "Shinya", 
        "id": "sg:person.0644725370.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644725370.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan", 
          "id": "http://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyake", 
        "givenName": "Teruki", 
        "id": "sg:person.01322775103.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322775103.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Saiseikei Matusyama Hospital, Matsuyama, Ehime, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Saiseikei Matusyama Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyaoka", 
        "givenName": "Hiroaki", 
        "id": "sg:person.0625744560.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625744560.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Saiseikei Matusyama Hospital, Matsuyama, Ehime, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Saiseikei Matusyama Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuura", 
        "givenName": "Bunzo", 
        "id": "sg:person.0607425152.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607425152.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Lifestyle-Related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan", 
          "id": "http://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Department of Lifestyle-Related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hiasa", 
        "givenName": "Yoichi", 
        "id": "sg:person.01333031252.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333031252.69"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00125-012-2746-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046744549", 
          "https://doi.org/10.1007/s00125-012-2746-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-016-0350-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003457836", 
          "https://doi.org/10.1007/s12325-016-0350-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ijo.2015.96", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015739333", 
          "https://doi.org/10.1038/ijo.2015.96"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13690-016-0130-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004781331", 
          "https://doi.org/10.1186/s13690-016-0130-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-018-0366-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100290978", 
          "https://doi.org/10.1007/s13300-018-0366-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ijo.0802425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005400823", 
          "https://doi.org/10.1038/sj.ijo.0802425"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-04-15", 
    "datePublishedReg": "2022-04-15", 
    "description": "IntroductionLuseogliflozin is a sodium-glucose cotransporter\u00a02 (SGLT2) inhibitor. Unhealthy eating behavior is associated with diabetes, hypertension, and obesity. However, evidence regarding the effect of medications, including SGLT2 inhibitors, on unhealthy eating behavior is limited. This study investigated the association between unhealthy eating behavior and the laboratory and physical findings of Japanese patients with type 2 diabetes given luseogliflozin once daily for 24\u00a0weeks.MethodsTwenty-nine patients with type 2 diabetes mellitus were enrolled in a 24-week prospective, open-label, single-arm pilot study. The information regarding unhealthy eating behaviors (eating fast, late dinner, nighttime snack, skipping breakfast, and eating until full) was obtained using self-reported questionnaires.ResultsThe baseline rate of eating fast, late dinner, nighttime snack, skipping breakfast, and eating until full was 51.7%, 24.1%, 24.1%, 10.3% and 55.2%, respectively. After administration of luseogliflozin, fasting plasma glucose, HbA1c, aspartate aminotransferase (ALT), weight, body mass index, and waist measurement all decreased significantly. High-density lipoprotein cholesterol and hematocrit increased significantly. In the healthy eating behavior group, the improvements of fasting plasma glucose and ALT, but not other variables, were attenuated. HbA1c level was significantly improved in patients with eating fast, while other unhealthy eating behaviors attenuated the effect of luseogliflozin for HbA1c. The effect of leseogliflozin on the relationship between eating behavior and weight reduction was inconsistent after administration luseogliflozin.ConclusionLuseogliflozin might be more effective for controlling plasma glucose in patients with type 2 diabetes who have a tendency to eat fast, but it might have less effect on those with other unhealthy eating habits.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-022-01261-9", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "type 2 diabetes", 
      "plasma glucose", 
      "sodium-glucose cotransporter 2 inhibitors", 
      "high-density lipoprotein cholesterol", 
      "type 2 diabetes mellitus", 
      "single-arm pilot study", 
      "effect of luseogliflozin", 
      "MethodsTwenty-nine patients", 
      "cotransporter 2 inhibitors", 
      "body mass index", 
      "effects of medication", 
      "sodium-glucose cotransporter", 
      "unhealthy eating habits", 
      "nighttime snack", 
      "lipoprotein cholesterol", 
      "diabetes mellitus", 
      "SGLT2 inhibitors", 
      "mass index", 
      "physical findings", 
      "skipping breakfast", 
      "Japanese patients", 
      "waist measurement", 
      "observational study", 
      "unhealthy eating behaviours", 
      "self-report questionnaires", 
      "luseogliflozin", 
      "patients", 
      "aspartate aminotransferase", 
      "eating habits", 
      "late dinner", 
      "diabetes", 
      "pilot study", 
      "baseline rate", 
      "eating behaviors", 
      "weight reduction", 
      "behavior groups", 
      "inhibitors", 
      "glucose", 
      "hypertension", 
      "HbA1c", 
      "mellitus", 
      "medications", 
      "obesity", 
      "less effect", 
      "hematocrit", 
      "breakfast", 
      "ALT", 
      "study", 
      "cholesterol", 
      "administration", 
      "aminotransferase", 
      "weeks", 
      "effect", 
      "cotransporter", 
      "association", 
      "snacks", 
      "unhealthy", 
      "questionnaire", 
      "dinner", 
      "group", 
      "findings", 
      "habits", 
      "evidence", 
      "index", 
      "levels", 
      "weight", 
      "rate", 
      "reduction", 
      "improvement", 
      "Ehime", 
      "laboratory", 
      "variables", 
      "relationship", 
      "tendency", 
      "behavior", 
      "information", 
      "measurements"
    ], 
    "name": "Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study", 
    "pagination": "1073-1082", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1147145793"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-022-01261-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35426601"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-022-01261-9", 
      "https://app.dimensions.ai/details/publication/pub.1147145793"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_929.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-022-01261-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01261-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01261-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01261-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01261-9'


 

This table displays all metadata directly associated to this object as RDF triples.

197 TRIPLES      21 PREDICATES      108 URIs      94 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-022-01261-9 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N87754d21b6d14040a0649d625239b6ce
4 schema:citation sg:pub.10.1007/s00125-012-2746-3
5 sg:pub.10.1007/s12325-016-0350-5
6 sg:pub.10.1007/s13300-018-0366-8
7 sg:pub.10.1038/ijo.2015.96
8 sg:pub.10.1038/sj.ijo.0802425
9 sg:pub.10.1186/s13690-016-0130-3
10 schema:datePublished 2022-04-15
11 schema:datePublishedReg 2022-04-15
12 schema:description IntroductionLuseogliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Unhealthy eating behavior is associated with diabetes, hypertension, and obesity. However, evidence regarding the effect of medications, including SGLT2 inhibitors, on unhealthy eating behavior is limited. This study investigated the association between unhealthy eating behavior and the laboratory and physical findings of Japanese patients with type 2 diabetes given luseogliflozin once daily for 24 weeks.MethodsTwenty-nine patients with type 2 diabetes mellitus were enrolled in a 24-week prospective, open-label, single-arm pilot study. The information regarding unhealthy eating behaviors (eating fast, late dinner, nighttime snack, skipping breakfast, and eating until full) was obtained using self-reported questionnaires.ResultsThe baseline rate of eating fast, late dinner, nighttime snack, skipping breakfast, and eating until full was 51.7%, 24.1%, 24.1%, 10.3% and 55.2%, respectively. After administration of luseogliflozin, fasting plasma glucose, HbA1c, aspartate aminotransferase (ALT), weight, body mass index, and waist measurement all decreased significantly. High-density lipoprotein cholesterol and hematocrit increased significantly. In the healthy eating behavior group, the improvements of fasting plasma glucose and ALT, but not other variables, were attenuated. HbA1c level was significantly improved in patients with eating fast, while other unhealthy eating behaviors attenuated the effect of luseogliflozin for HbA1c. The effect of leseogliflozin on the relationship between eating behavior and weight reduction was inconsistent after administration luseogliflozin.ConclusionLuseogliflozin might be more effective for controlling plasma glucose in patients with type 2 diabetes who have a tendency to eat fast, but it might have less effect on those with other unhealthy eating habits.
13 schema:genre article
14 schema:isAccessibleForFree true
15 schema:isPartOf N42f4cd7ef4f34fd9ade14331fdc344e8
16 Ndf843125110b41e29a4e8a3ebbebd2c4
17 sg:journal.1044057
18 schema:keywords ALT
19 Ehime
20 HbA1c
21 Japanese patients
22 MethodsTwenty-nine patients
23 SGLT2 inhibitors
24 administration
25 aminotransferase
26 aspartate aminotransferase
27 association
28 baseline rate
29 behavior
30 behavior groups
31 body mass index
32 breakfast
33 cholesterol
34 cotransporter
35 cotransporter 2 inhibitors
36 diabetes
37 diabetes mellitus
38 dinner
39 eating behaviors
40 eating habits
41 effect
42 effect of luseogliflozin
43 effects of medication
44 evidence
45 findings
46 glucose
47 group
48 habits
49 hematocrit
50 high-density lipoprotein cholesterol
51 hypertension
52 improvement
53 index
54 information
55 inhibitors
56 laboratory
57 late dinner
58 less effect
59 levels
60 lipoprotein cholesterol
61 luseogliflozin
62 mass index
63 measurements
64 medications
65 mellitus
66 nighttime snack
67 obesity
68 observational study
69 patients
70 physical findings
71 pilot study
72 plasma glucose
73 questionnaire
74 rate
75 reduction
76 relationship
77 self-report questionnaires
78 single-arm pilot study
79 skipping breakfast
80 snacks
81 sodium-glucose cotransporter
82 sodium-glucose cotransporter 2 inhibitors
83 study
84 tendency
85 type 2 diabetes
86 type 2 diabetes mellitus
87 unhealthy
88 unhealthy eating behaviours
89 unhealthy eating habits
90 variables
91 waist measurement
92 weeks
93 weight
94 weight reduction
95 schema:name Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study
96 schema:pagination 1073-1082
97 schema:productId N64252a83a52044cbb9fec04549a7ca5a
98 N718a255ea55d4997a5bdc7d57553e6f3
99 Ne97058501bfe438c97b4538757f6a51b
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1147145793
101 https://doi.org/10.1007/s13300-022-01261-9
102 schema:sdDatePublished 2022-10-01T06:50
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N8311700283fc413782b2320d8391963e
105 schema:url https://doi.org/10.1007/s13300-022-01261-9
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N42f4cd7ef4f34fd9ade14331fdc344e8 schema:volumeNumber 13
110 rdf:type schema:PublicationVolume
111 N64252a83a52044cbb9fec04549a7ca5a schema:name pubmed_id
112 schema:value 35426601
113 rdf:type schema:PropertyValue
114 N718a255ea55d4997a5bdc7d57553e6f3 schema:name doi
115 schema:value 10.1007/s13300-022-01261-9
116 rdf:type schema:PropertyValue
117 N78d47a2faef64bbd9334606edf8ff64f rdf:first sg:person.0607425152.67
118 rdf:rest Nc1936c8e96244dfd982122b8a1f37af9
119 N7a0264b25e1243428f65f79dcdb26b03 rdf:first sg:person.01322775103.66
120 rdf:rest Ndf32d95852bd4f05a7c4eae6c176aba2
121 N8311700283fc413782b2320d8391963e schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N87754d21b6d14040a0649d625239b6ce rdf:first sg:person.0644725370.29
124 rdf:rest N7a0264b25e1243428f65f79dcdb26b03
125 Nc1936c8e96244dfd982122b8a1f37af9 rdf:first sg:person.01333031252.69
126 rdf:rest rdf:nil
127 Ndf32d95852bd4f05a7c4eae6c176aba2 rdf:first sg:person.0625744560.75
128 rdf:rest N78d47a2faef64bbd9334606edf8ff64f
129 Ndf843125110b41e29a4e8a3ebbebd2c4 schema:issueNumber 5
130 rdf:type schema:PublicationIssue
131 Ne97058501bfe438c97b4538757f6a51b schema:name dimensions_id
132 schema:value pub.1147145793
133 rdf:type schema:PropertyValue
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
138 schema:name Clinical Sciences
139 rdf:type schema:DefinedTerm
140 sg:journal.1044057 schema:issn 1869-6953
141 1869-6961
142 schema:name Diabetes Therapy
143 schema:publisher Springer Nature
144 rdf:type schema:Periodical
145 sg:person.01322775103.66 schema:affiliation grid-institutes:grid.255464.4
146 schema:familyName Miyake
147 schema:givenName Teruki
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322775103.66
149 rdf:type schema:Person
150 sg:person.01333031252.69 schema:affiliation grid-institutes:grid.255464.4
151 schema:familyName Hiasa
152 schema:givenName Yoichi
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333031252.69
154 rdf:type schema:Person
155 sg:person.0607425152.67 schema:affiliation grid-institutes:None
156 schema:familyName Matsuura
157 schema:givenName Bunzo
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607425152.67
159 rdf:type schema:Person
160 sg:person.0625744560.75 schema:affiliation grid-institutes:None
161 schema:familyName Miyaoka
162 schema:givenName Hiroaki
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625744560.75
164 rdf:type schema:Person
165 sg:person.0644725370.29 schema:affiliation grid-institutes:grid.255464.4
166 schema:familyName Furukawa
167 schema:givenName Shinya
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644725370.29
169 rdf:type schema:Person
170 sg:pub.10.1007/s00125-012-2746-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046744549
171 https://doi.org/10.1007/s00125-012-2746-3
172 rdf:type schema:CreativeWork
173 sg:pub.10.1007/s12325-016-0350-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003457836
174 https://doi.org/10.1007/s12325-016-0350-5
175 rdf:type schema:CreativeWork
176 sg:pub.10.1007/s13300-018-0366-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100290978
177 https://doi.org/10.1007/s13300-018-0366-8
178 rdf:type schema:CreativeWork
179 sg:pub.10.1038/ijo.2015.96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015739333
180 https://doi.org/10.1038/ijo.2015.96
181 rdf:type schema:CreativeWork
182 sg:pub.10.1038/sj.ijo.0802425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005400823
183 https://doi.org/10.1038/sj.ijo.0802425
184 rdf:type schema:CreativeWork
185 sg:pub.10.1186/s13690-016-0130-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004781331
186 https://doi.org/10.1186/s13690-016-0130-3
187 rdf:type schema:CreativeWork
188 grid-institutes:None schema:alternateName Department of Internal Medicine, Saiseikei Matusyama Hospital, Matsuyama, Ehime, Japan
189 schema:name Department of Internal Medicine, Saiseikei Matusyama Hospital, Matsuyama, Ehime, Japan
190 rdf:type schema:Organization
191 grid-institutes:grid.255464.4 schema:alternateName Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan
192 Department of Lifestyle-Related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan
193 Health Services Center, Ehime University, Bunkyo, 790-8577, Matsuyama, Ehime, Japan
194 schema:name Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan
195 Department of Lifestyle-Related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan
196 Health Services Center, Ehime University, Bunkyo, 790-8577, Matsuyama, Ehime, Japan
197 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...